174 related articles for article (PubMed ID: 17473952)
21. Myo9B is associated with an increased risk of Barrett's esophagus and esophageal adenocarcinoma.
Menke V; Van Zoest KP; Moons LM; Pot RG; Siersema PD; Kuipers EJ; Kusters JG
Scand J Gastroenterol; 2012 Dec; 47(12):1422-8. PubMed ID: 22954106
[TBL] [Abstract][Full Text] [Related]
22. Increased p53 expression in the malignant transformation of Barrett's esophagus is accompanied by an upward shift of the proliferative compartment.
Hritz I; Gyorffy H; Molnar B; Lakatos G; Sipos F; Pregun I; Juhasz M; Pronai L; Schaff Z; Tulassay Z; Herszenyi L
Pathol Oncol Res; 2009 Jun; 15(2):183-92. PubMed ID: 18752044
[TBL] [Abstract][Full Text] [Related]
23. Effect of freeze-dried berries on the development of reflux-induced esophageal adenocarcinoma.
Aiyer HS; Li Y; Losso JN; Gao C; Schiffman SC; Slone SP; Martin RC
Nutr Cancer; 2011 Nov; 63(8):1256-62. PubMed ID: 22043833
[TBL] [Abstract][Full Text] [Related]
24. Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma.
Kauttu T; Mustonen H; Vainionpää S; Krogerus L; Ilonen I; Räsänen J; Salo J; Puolakkainen P
Clin Transl Oncol; 2017 Jan; 19(1):58-66. PubMed ID: 27026568
[TBL] [Abstract][Full Text] [Related]
25. Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation.
Woodall CE; Li Y; Liu QH; Wo J; Martin RC
Anticancer Drugs; 2009 Jul; 20(6):437-43. PubMed ID: 19398904
[TBL] [Abstract][Full Text] [Related]
26. Metabolomics study of esophageal adenocarcinoma.
Zhang J; Liu L; Wei S; Nagana Gowda GA; Hammoud Z; Kesler KA; Raftery D
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):469-75, 475.e1-4. PubMed ID: 20880550
[TBL] [Abstract][Full Text] [Related]
27. Selective decrease in the DNA base excision repair pathway in squamous cell cancer of the esophagus.
Bonde P; Gao D; Chen L; Duncan M; Miyashita T; Montgomery E; Harmon JW; Wei C
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):74-81. PubMed ID: 17198784
[TBL] [Abstract][Full Text] [Related]
28. [Does symptomatic gastroesophageal reflux present a risk factor for development of adenocarcinoma of the esophagus?].
Kellner H; Zoller WG
Z Gastroenterol; 1999 Oct; 37(10):1071-3. PubMed ID: 10549101
[No Abstract] [Full Text] [Related]
29. Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett's esophagus and esophageal adenocarcinoma.
Li Y; Martin RC
Dis Esophagus; 2007; 20(5):372-8. PubMed ID: 17760649
[TBL] [Abstract][Full Text] [Related]
30. Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma.
Goldstein SR; Yang GY; Chen X; Curtis SK; Yang CS
Carcinogenesis; 1998 Aug; 19(8):1445-9. PubMed ID: 9744541
[TBL] [Abstract][Full Text] [Related]
31. COX-2 CA-haplotype is a risk factor for the development of esophageal adenocarcinoma.
Moons LM; Kuipers EJ; Rygiel AM; Groothuismink AZ; Geldof H; Bode WA; Krishnadath KK; Bergman JJ; van Vliet AH; Siersema PD; Kusters JG
Am J Gastroenterol; 2007 Nov; 102(11):2373-9. PubMed ID: 17581270
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.
Bonde P; Sui G; Dhara S; Wang J; Broor A; Kim IF; Wiley JE; Marti G; Duncan M; Jaffee E; Montgomery E; Maitra A; Harmon JW
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):763-9. PubMed ID: 17320581
[TBL] [Abstract][Full Text] [Related]
33. The resistance of esophageal adenocarcinoma to bile salt insult is associated with manganese superoxide dismutase expression.
Schiffman SC; Li Y; Xiao D; Li X; Aiyer HS; Martin RC
J Surg Res; 2011 Dec; 171(2):623-30. PubMed ID: 20638682
[TBL] [Abstract][Full Text] [Related]
34. Duodenal reflux leads to down regulation of DNA mismatch repair pathway in an animal model of esophageal cancer.
Bonde P; Gao D; Chen L; Miyashita T; Montgomery E; Harmon JW; Wei C
Ann Thorac Surg; 2007 Feb; 83(2):433-40; discussion 440. PubMed ID: 17257966
[TBL] [Abstract][Full Text] [Related]
35. A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett's esophagus and esophageal adenocarcinoma.
Murphy SJ; Hughes AE; Patterson CC; Anderson LA; Watson RG; Johnston BT; Comber H; McGuigan J; Reynolds JV; Murray LJ
Carcinogenesis; 2007 Jun; 28(6):1323-8. PubMed ID: 17277236
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and molecular biology of Barrett esophagus.
Casson AG; Williams L; Guernsey DL
Semin Thorac Cardiovasc Surg; 2005; 17(4):284-91. PubMed ID: 16428034
[TBL] [Abstract][Full Text] [Related]
37. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
Abraham SC; Wang H; Wang KK; Wu TT
Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
[TBL] [Abstract][Full Text] [Related]
38. High yield reproducible rat model recapitulating human Barrett's carcinogenesis.
Matsui D; Omstead AN; Kosovec JE; Komatsu Y; Lloyd EJ; Raphael H; Kelly RJ; Zaidi AH; Jobe BA
World J Gastroenterol; 2017 Sep; 23(33):6077-6087. PubMed ID: 28970723
[TBL] [Abstract][Full Text] [Related]
39. Colocalization of MnSOD expression in response to oxidative stress.
Li Y; Reuter NP; Li X; Liu Q; Zhang J; Martin RC
Mol Carcinog; 2010 Jan; 49(1):44-53. PubMed ID: 19623544
[TBL] [Abstract][Full Text] [Related]
40. Secretory phospholipase A2 is required to produce histologic changes associated with gastroduodenal reflux in a murine model.
Babu A; Meng X; Banerjee AM; Gamboni-Robertson F; Cleveland JC; Damle S; Fullerton DA; Weyant MJ
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1220-7. PubMed ID: 18544357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
